Journal
VIRUSES-BASEL
Volume 11, Issue 3, Pages -Publisher
MDPI
DOI: 10.3390/v11030206
Keywords
Ebola virus; Marburg virus; filoviruses; viral entry; macropinocytosis; diacylglycerol kinase
Categories
Funding
- Canadian Institutes of Health Research [ER1-143489, PJT148634, PJT155984]
- Natural Sciences and Engineering Research Council of Canada
- Ontario Graduate Scholarship
- Public Health Agency of Canada
- CIHR New Investigator Award [MSH141981]
- Ontario Ministry of Research, Innovation and Science Early Researcher Award
Ask authors/readers for more resources
Filoviruses, such as Ebola virus (EBOV) and Marburg virus, are causative agents of unpredictable outbreaks of severe hemorrhagic fevers in humans and non-human primates. For infection, filoviral particles need to be internalized and delivered to intracellular vesicles containing cathepsin proteases and the viral receptor Niemann-Pick C1. Previous studies have shown that EBOV triggers macropinocytosis of the viral particles in a glycoprotein (GP)-dependent manner, but the molecular events required for filovirus internalization remain mostly unknown. Here we report that the diacylglycerol kinase inhibitor, R-59-022, blocks EBOV GP-mediated entry into Vero cells and bone marrow-derived macrophages. Investigation of the mode of action of the inhibitor revealed that it blocked an early step in entry, more specifically, the internalization of the viral particles via macropinocytosis. Finally, R-59-022 blocked viral entry mediated by a panel of pathogenic filovirus GPs and inhibited growth of replicative Ebola virus. Taken together, our studies suggest that R-59-022 could be used as a tool to investigate macropinocytic uptake of filoviruses and could be a starting point for the development of pan-filoviral therapeutics.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available